X4 Pharmaceuticals’ Post

View organization page for X4 Pharmaceuticals, graphic

10,462 followers

Don't forget to register for our June 27th virtual investor event where we will review new clinical data on our lead product candidate from our ongoing Phase 2 trial in #ChronicNeutropenia. We are excited to include renowned experts Dr. Jean Donadieu, MD, PhD, and Dr. Peter E. Newburger, MD, who will share their insights on the interim results and the high unmet need in CN.    Register now by clicking the link here: https://bit.ly/3VuyTQu    #Progress4Patients

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics